Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ecke

Showing results (111-120 of 140) with videos related to

Pageof 14
Sort By:
Clinical Chemistry and Laboratory Medicine|October 3, 2014
Urinary thiosulfate as failed prostate cancer biomarker - an exemplary multicenter re-evaluation studyCarsten Stephan, Jacek Wilkosz, Waldemar Różański, et al.
The Journal of International Medical Research|April 19, 2017
Retrospective analysis of a surgical innovation using the IDEAL framework: radical cystectomy with epidural anaesthesiaHolger Gerullis, Thorsten H Ecke, Dimitri Barski, et al.
Urologia Internationalis|February 22, 2017
Transvesical Suprapubic Externalization of Ureteral Stents - Introduction of a Surgical Innovation at the Development StageHolger Gerullis, Klaus Schwartmann, Thorsten H Ecke, et al.
Nature Reviews. Urology|August 19, 2025
Urinary bladder cancer needs more attention - recommendations for health care professionals and politicians in the European UnionThorsten H Ecke, Sarah Collen, Alex Filicevas, et al.
Urologic Oncology|February 10, 2021
Comparison of initial and second opinion reads of multiparametric magnetic resonance imaging of the prostate for transperineal template-guided biopsies with MRI-Ultrasound fusionThorsten H Ecke, Dagmar Schwaiger, Gregorij Nesterov, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 6, 2023
Considering the Effects of Modern Point-of-Care Urine Biomarker Assays in Follow-Up of Patients with High-Risk Non-muscle-Invasive Bladder CancerThorsten H Ecke, Natalya Benderska-Söder, Ekkehardt Bismarck, et al.
Medical Oncology (Northwood, London, England)|March 27, 2012
A phase II trial of temsirolimus in second-line metastatic urothelial cancerH Gerullis, C Eimer, T H Ecke, et al.
European Urology Open Science|August 2, 2021
Identifying the Molecular Mechanisms Contributing to Progression, Metastasis, and Death in Low-grade Non-muscle-invasive Bladder Cancer: A Case ReportSarah Weiß, Steffen Hallmann, Stefan Koch, et al.
Anticancer Research|July 2, 2010
TP53 gene mutations in prostate cancer progressionThorsten H Ecke, Horst H Schlechte, Katrin Schiemenz, et al.
Anticancer Research|October 26, 2022
Luminophore Chemistry for Detection of Urinary Bladder Cancer - Comparison to Cytology and Urinary Rapid Tests (BTA stat<sup>®</sup>, NMP22<sup>®</sup> BladderChek<sup>®</sup> and UBC<sup>®</sup> <i>Rapid</i> Test)Thorsten H Ecke, Mikolaj Scislowski, Nazia Hassan, et al.
Pageof 14

Showing results (111-120 of 140) with videos related to

Sort By:
Pageof 14
Clinical Chemistry and Laboratory Medicine|October 3, 2014
Urinary thiosulfate as failed prostate cancer biomarker - an exemplary multicenter re-evaluation studyCarsten Stephan, Jacek Wilkosz, Waldemar Różański, et al.
The Journal of International Medical Research|April 19, 2017
Retrospective analysis of a surgical innovation using the IDEAL framework: radical cystectomy with epidural anaesthesiaHolger Gerullis, Thorsten H Ecke, Dimitri Barski, et al.
Urologia Internationalis|February 22, 2017
Transvesical Suprapubic Externalization of Ureteral Stents - Introduction of a Surgical Innovation at the Development StageHolger Gerullis, Klaus Schwartmann, Thorsten H Ecke, et al.
Nature Reviews. Urology|August 19, 2025
Urinary bladder cancer needs more attention - recommendations for health care professionals and politicians in the European UnionThorsten H Ecke, Sarah Collen, Alex Filicevas, et al.
Urologic Oncology|February 10, 2021
Comparison of initial and second opinion reads of multiparametric magnetic resonance imaging of the prostate for transperineal template-guided biopsies with MRI-Ultrasound fusionThorsten H Ecke, Dagmar Schwaiger, Gregorij Nesterov, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 6, 2023
Considering the Effects of Modern Point-of-Care Urine Biomarker Assays in Follow-Up of Patients with High-Risk Non-muscle-Invasive Bladder CancerThorsten H Ecke, Natalya Benderska-Söder, Ekkehardt Bismarck, et al.
Medical Oncology (Northwood, London, England)|March 27, 2012
A phase II trial of temsirolimus in second-line metastatic urothelial cancerH Gerullis, C Eimer, T H Ecke, et al.
European Urology Open Science|August 2, 2021
Identifying the Molecular Mechanisms Contributing to Progression, Metastasis, and Death in Low-grade Non-muscle-invasive Bladder Cancer: A Case ReportSarah Weiß, Steffen Hallmann, Stefan Koch, et al.
Anticancer Research|July 2, 2010
TP53 gene mutations in prostate cancer progressionThorsten H Ecke, Horst H Schlechte, Katrin Schiemenz, et al.
Anticancer Research|October 26, 2022
Luminophore Chemistry for Detection of Urinary Bladder Cancer - Comparison to Cytology and Urinary Rapid Tests (BTA stat<sup>®</sup>, NMP22<sup>®</sup> BladderChek<sup>®</sup> and UBC<sup>®</sup> <i>Rapid</i> Test)Thorsten H Ecke, Mikolaj Scislowski, Nazia Hassan, et al.
Pageof 14